Medical device giant Stryker has announced it has tapped former DePuy Orthopaedics CEO as the new president of its orthopedics division. According to a report from MassDevice.com, David Floyd left DePuy in March, amid controversy surround the recall of its DePuy ASR hip implants, and the ongoing DePuy Pinnacle hip lawsuit litigation.

Floyd joined DePuy in 2007, and by the time he left the company, the metal-on-metal hip controversy created by the August 2010 DePuy ASR hip recall and resulting legal actions had already cost the Johnson & Johnson division $1 billion. According to a Reuters report published over the summer, legal experts believe litigation involving a metal-on-metal version of the DePuy Pinnacle hip implant system could cost the companies as much as $5 billion. DePuy is facing some 8,000 legal claims over the ASR device, and more than 2,900 DePuy Pinnacle hip lawsuits.

The DePuy ASR recall helped to set off a storm of controversy over the safety of metal-on-metal hip implants. The U.S. Food & Drug Administration (FDA) is now conducting a safety review of all-metal hip replacements, amid concerns that they can shed dangerous amounts of metal debris into patients’ tissue and blood stream. This can lead to an adverse tissue reaction called metallosis, loosening of the joint, pain, early implant failure, and possibly other health problems down the road.

According to the MassDevice.com report, Floyd will join Stryker effective November 15th. Considering the events that transpired while Floyd was heading up DePuy, Strykers’ choice may seem odd to some, as the company is currently facing its own metal hip implant storm. Stryker recalled its Rejuvenate and ABG II modular-neck stem components in July because of a risk of fretting and corrosion at the modular-neck junction. Stryker warned in its recall notice that patients with the Rejuvenate or AGB II hip implant components may develop adverse local tissue reactions that could manifest with symptoms of pain and/or swelling.

According to the company, some 20,000 of the affected implants had been sold prior to the Stryker hip recall. Last month during its earnings call, Stryker acknowledged that an approximate 2% increase in hip implant sales reflected, among other things, a “modest” hit from the recent Stryker hip recall. The company is now facing a wave of Stryker Rejuvenate lawsuits filed by people who allegedly suffered metal poisoning and other injuries due to the recalled implants. Recently, plaintiffs requested that all Stryker hip recall lawsuits filed in New Jersey Superior Court be assigned to Judge Brian Martinottii in Bergen County.

If you were injured by a DePuy Pinnacle hip implant, or any other metal-on-metal hip replacement device, you may be entitled to compensation for your pain and suffering. To learn more about DePuy Pinnacle hip lawsuits, please give the attorneys of Bernstein Liebhard LLP a call, at 1-877-779-1414.

Published November 15, 2012 by